virus infection

Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance

An engineered 5-helix bundle derived from SARS-CoV-2 S2 pre-binds sarbecoviral spike at both serological- and endosomal-pH to inhibit virus entry

SARS-CoV-2 S2에서 파생된 조작된 5나선 번들은 바이러스 진입을 억제하기 위해 혈청학적 pH와 엔도솜 pH 모두에서 사베코바이러스 스파이크를 사전 결합합니다.

Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates

A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants

비강 오미크론 백신 부스터는 새로운 SARS-CoV-2 변이체에 대한 강력한 중화 항체 반응을 이끌어냅니다.

COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges

COVID-19 비강내 백신: 현재 진행 상황, 이점, 전망 및 과제

Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches

ColdZyme® protects airway epithelia from infection with BA.4/5

SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model

Comparative Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in the Ferret Model

Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein